Results 1 to 10 of about 336,163 (140)

Fibroblast circSamd4 promotes cardiac fibrosis via activating plasminogen activator inhibitor-1 [PDF]

open access: yesRedox Biology
Cardiac fibrosis remains an unresolved clinical issue in patients with heart diseases. CircRNAs have emerged as potential targets for treatment of heart diseases.
Yan Chen   +13 more
doaj   +2 more sources

LncRNA nonnmmut065573 promotes post-myocardial infarction cardiac fibrosis and activates the TGF-β1/ZEB1 pathway [PDF]

open access: yesCell Regeneration
Cardiac fibrosis following myocardial infarction (MI) is a critical determinant of progressive cardiac dysfunction, yet the underlying mechanisms driving this pathological process remain incompletely understood.
Chaowei Hu   +13 more
doaj   +2 more sources

Revolutionizing cardiac fibrosis treatment: the potential of personalized CAR T-cell therapy [PDF]

open access: yesCardio-Oncology
Cardiac fibrosis, a condition characterized by the deposition of excess collagen in the cardiac tissue, is a major complication of various cardiovascular diseases, including myocardial infarction, hypertension, and different types of cardiomyopathies ...
Soroush Taherkhani   +3 more
doaj   +2 more sources

Ubiquitin proteasome system in cardiac fibrosis [PDF]

open access: yesJournal of Advanced Research
Background: Cardiac fibrosis, including reactive fibrosis and replacement fibrosis, is a common pathological process in most cardiovascular diseases.
Linqi Zeng   +7 more
doaj   +2 more sources

Exploring the cardiac ECM during fibrosis: A new era with next-gen proteomics

open access: yesFrontiers in Molecular Biosciences, 2022
Extracellular matrix (ECM) plays a critical role in maintaining elasticity in cardiac tissues. Elasticity is required in the heart for properly pumping blood to the whole body. Dysregulated ECM remodeling causes fibrosis in the cardiac tissues.
Vivek Sarohi   +5 more
doaj   +1 more source

Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice

open access: yesMicrobiology Spectrum, 2022
Cardiac fibrosis is an integral aspect of every form of cardiovascular diseases, which is one of the leading causes of death worldwide. It is urgent to explore new effective drugs and treatments.
Jiaqi Wang   +7 more
doaj   +1 more source

Leonurine inhibits cardiomyocyte pyroptosis to attenuate cardiac fibrosis via the TGF-β/Smad2 signalling pathway.

open access: yesPLoS ONE, 2022
Cardiac fibrosis is a common cause of most cardiovascular diseases. Leonurine, an alkaloid from Herba leonuri, had been indicated to treat cardiovascular diseases due to its cardioprotective effects.
Zhaoyi Li, Keyuan Chen, Yi Zhun Zhu
doaj   +1 more source

Promising Therapeutic Treatments for Cardiac Fibrosis: Herbal Plants and Their Extracts

open access: yesCardiology and Therapy, 2023
Cardiac fibrosis is closely associated with multiple heart diseases, which are a prominent health issue in the global world. Neurohormones and cytokines play indispensable roles in cardiac fibrosis. Many signaling pathways participate in cardiac fibrosis
Xuejing Yu
doaj   +1 more source

Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation

open access: yesMolecules, 2023
(1) Background: Heart failure (HF) is the final stage of multiple cardiac diseases, which have now become a severe public health problem worldwide.
Wenqi Li   +14 more
doaj   +1 more source

Proteomic Insights into Cardiac Fibrosis: From Pathophysiological Mechanisms to Therapeutic Opportunities

open access: yesMolecules, 2022
Cardiac fibrosis is a common pathophysiologic process in nearly all forms of heart disease which refers to excessive deposition of extracellular matrix proteins by cardiac fibroblasts.
Ruiqiang Qi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy